Everolimus
Everolimus is a potent mTOR inhibitor that binds to FKBP-12. It is used alone or in combination with calcineurin inhibitors.
| Catalog Number | T1784 |
| Alternative Name(s) | RAD001 , SDZ-RAD |
| Research Area | Others|||Autophagy|||Apoptosis|||PI3K/Akt/mTOR signaling |
| Molecular Formula | C53H83NO14 |
| CAS# | 159351-69-6 |
| Purity | 99.52% |
| SMILES | CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OCCO |
| Size | 200 mg |
| Supplier Page | https://www.targetmol.com/compound/Everolimus |
| Additional Information | https://www.targetmol.com/datasheet/T1784 |